- Home
- CTXR vs DALN Comparison
CTXR vs DALN Comparison
Compare CTXR & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- DALN
- Stock Information
- Founded
- CTXR 2007
- DALN 1954
- Country
- CTXR United States
- DALN United States
- Employees
- CTXR N/A
- DALN N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- DALN Newspapers/Magazines
- Sector
- CTXR Health Care
- DALN Consumer Discretionary
- Exchange
- CTXR Nasdaq
- DALN Nasdaq
- Market Cap
- CTXR 28.4M
- DALN 24.6M
- IPO Year
- CTXR N/A
- DALN 2008
- Fundamental
- Price
- CTXR $3.30
- DALN $6.79
- Analyst Decision
- CTXR Strong Buy
- DALN
- Analyst Count
- CTXR 2
- DALN 0
- Target Price
- CTXR $54.50
- DALN N/A
- AVG Volume (30 Days)
- CTXR 185.5K
- DALN 54.4K
- Earning Date
- CTXR 02-12-2025
- DALN 03-05-2025
- Dividend Yield
- CTXR N/A
- DALN 2.36%
- EPS Growth
- CTXR N/A
- DALN N/A
- EPS
- CTXR N/A
- DALN N/A
- Revenue
- CTXR N/A
- DALN $128,286,000.00
- Revenue This Year
- CTXR N/A
- DALN N/A
- Revenue Next Year
- CTXR $216.25
- DALN N/A
- P/E Ratio
- CTXR N/A
- DALN N/A
- Revenue Growth
- CTXR N/A
- DALN N/A
- 52 Week Low
- CTXR $2.44
- DALN $2.98
- 52 Week High
- CTXR $26.75
- DALN $7.86
- Technical
- Relative Strength Index (RSI)
- CTXR 41.54
- DALN 54.49
- Support Level
- CTXR $3.70
- DALN $6.75
- Resistance Level
- CTXR $4.43
- DALN $7.19
- Average True Range (ATR)
- CTXR 0.54
- DALN 0.34
- MACD
- CTXR 0.06
- DALN -0.09
- Stochastic Oscillator
- CTXR 6.03
- DALN 8.41
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.